DR. MARC PLAWKER M.D. NPI 1588642250

NPI Details

DR. Marc Plawker, M.D. is a specialist in Staten Island, NY with 34 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Marc Plawker, M.D. NPI is 1588642250. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2454 HYLAN BLVD
STATEN ISLAND, NY
ZIP 10306-117
Phone: (718) 233-1300
Fax: (718) 980-9728

The NPI 1588642250 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Automated urinalysis test (HCPCS:81003)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Cell examination of urine, manual (HCPCS:88120)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Electronic assessment of bladder emptying (HCPCS:51741)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Application of electrical stimulation with therapist present, each 15 minutes (HCPCS:97032)
• Assessment of muscle signal of pelvic nerves (HCPCS:51792)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Study of rectum sensitivity and function (HCPCS:91122)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Simple measurement of pressure of urine flow in bladder (HCPCS:51725)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Complete ultrasound study of arm and leg arteries (HCPCS:93923)
• Biopsy of prostate gland (HCPCS:55700)
• Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Injection of drug or substance into vein (HCPCS:96374)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Complete ultrasound of abdomen and pelvis artery and vein blood flow (HCPCS:93975)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 1/4/2006 and was last updated on 2/21/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.